Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: An autopsy study

Neuromuscular Disorders

Volumn 9, Issue 2, 1999, Pages 86-94

  Taratuto, A L ^a   Lubieniecki, F ^a   Diaz D ^a   Schultz, M ^b   Ruggieri, V ^a   Saccoliti, M ^b   Dubrovsky, A ^c  

^a Servicio de Hemato Oncologia   (Argentina)

^b FLENI   (Argentina)

^c HOSPITAL FRANCÉS   (Argentina)

Author keywords

Cardiac muscle merosin deficiency; Cortical dysplasia; Merosin deficient congenital muscular dystrophy

Indexed keywords

MEROSIN;

AGYRIA; ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN MEMBRANE; CASE REPORT; CEREBELLUM HYPOPLASIA; CEREBELLUM VERMIS; DISEASE ASSOCIATION; GLIA; HETEROTOPIA; HUMAN; HUMAN TISSUE; INFANT; MALE; MICROGYRIA; MUSCULAR DYSTROPHY; OCCIPITAL CORTEX; PRIORITY JOURNAL; SKIN BLOOD VESSEL;

AUTOPSY; BIOPSY; CEREBRAL CORTEX; HUMANS; INFANT; LAMININ; MALE; MUSCULAR DYSTROPHIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032904645     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00112-6     Document Type: Article

References (36)

1. Tome FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with alpha 2 laminin deficiency. CR Acad Sci Paris Life Sci 1994;317:351-357.
2. Hillaire D, Leclerc A, Faure S, et al. Localisation of laminin alpha 2 chain- negative congenital muscular dystrophy to chromosome 6q 2 by homozygozity mapping. Hum Mol Genet 1994;3:1657-1661.
3. Fardeau M, Tome F, Helbing-Leclerc A, et al. Congenital muscular dystrophy with alpha 2 laminin deficiency: clinical, histopathologycal, immunocytochemical and genetic reports (in French). Rev Neurol (Paris) 1996;152:110-119.
4. Mercuri E, Muntoni F, Berardinelli A, Pennock J, Dubowitz V. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropediatrics 1995;26:3-7.
5. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-305.
6. Fukuyama Y, Osawa M, Suzuki H. Congenital muscular dystrophy of the Fukuyama type. Clinical, genetic, and pathological considerations. Brain Dev (Tokyo) 1981;3:1-29.
7. Dobyns WB, Pagon AR, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32:195-210.
8. Santavuori P, Leisti J, Kruus S. Muscle, eye and brain disease: a new syndrome (abstract). Neuropediatrie 1977;8 (Suppl.):553.
9. Sunada Y, Edgar TS, Lotz BP, Rust RS, Campbell KP. Laminin alpha 2 chain-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995;45:2084-2089.
10. Pini A, Merlini L, Tome FMS, Chevallay M, Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families. Brain Dev 1996;18:316-322.
11. Trevisan CP, Martinello F, Fanin M, Astorello E, Angelini C, Javicoli R. Laminin alpha 2 chain expression in muscle of Western cases with Fukuyama-like congenital muscular dystrophy. CP1. Abstract First Congress of the World Muscle Society. Neuromusc Disord 1996;Suppl:S21.
12. Van der Knaap MS, Smit LME, Barth PG, et al. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997;42:50-59.
13. Tiger CF, Champliaud MF, Pedrosa-Domello F, Thornell LE, Ekblom P, Gullberg D. Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies. J Biol Chem 1997;272:28590-28595.
14. Van der Knaap MS, Valk J. Congenital muscular dystrophy. In: Magnetic resonance of myelin, myelination and myelin disorders, second ed. New York: Springer 1995:267-276.
15. Mercuri E, Pennock J, Goodwin F, et al. Sequential study of central and peripheral nervous system involvement in an infant with laminin α2 chain-deficient congenital muscular dystrophy. Neuromusc Disord 1996;6:425-429.
16. Villanova M, Malandrini A, Sabatelli P, et al. Localization of laminin α2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta Neuropathol 1997;94:567-571.
17. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29.
18. Nakano I, Funahashi M, Takada K, Toda T. Are breaches in the glial limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus. Acta Neuropathol 1996;91:313-321.
19. Takada K. Fukuyama congenital muscular dystrophy as a unique disorder of neuronal migration: a neuropathological review and hypothesis. Yonago Acta Med 1988;31:1-16.
20. Yamamoto T, Komori T, Shibata N, et al. Fukuyama congenital muscular dystrophy: cortical dysplasia of the cerebrum in a 20-weeks fetus. Neuropathology 1996;16:184-189.
21. Yamamoto T, Toyoda C, Kobayashi M, Kondo E, Saito K, Osawa M. Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy. Brain Dev 1997;19:35-42.
22. Yamamoto T, Shibata N, Kanazawa M, et al. Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation. Acta Neuropathol 1997;94:173-179.
23. Gobbi P, Sewry CA, Muntoni F. Expression of sarcoglycans and laminin chains in human cardiac muscle (CO.7. Abstract). Neuromusc Disord 1998;8:237.
24. Muntoni F, Philpot J, Spyrou N, Camici P, Dubowitz V. Cardiac involvement in merosin-negative congenital muscular dystrophy. Dev Med Child Neurol 1995;72:37.
25. Poppe M, Herrmann R, Lorenz N, et al. Dilatative cardiomyopathy in a case of merosin-deficient congenital muscular dystrophy (CP7. Abstract). Neuromusc Disord 1998;8:239.
26. Sewry CA, Philpot J, Sorokin LM, et al. Diagnosis of laminin α2 chain (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 1996;347 (9001 ):582-584.
27. Sewry CA, D'Alessandro M, Wilson LA, et al. Expression of laminin chains in skin in laminin α2 chain-deficient congenital muscular dystrophy. Neuropediatrics 1997;28 (4):217-222.
28. Marbini A, Bellanova MF, Ferrari A, Lodesani M, Gemignani F. Immunohistochemical study of merosin-negative congenital muscular dystrophy: laminin α2 deficiency in skin biopsy. Acta Neuropathol 1997;94:103-108.
29. Squarzoni S, Villanova M, Sabatelli P, et al. Intracellular detection of laminin α2 chain in skin by electron microscopy immunocytochemistry: comparison between normal and laminin α2 chain deficient subjects. Neuromusc Disord 1997;7:91-98.
30. Pini A, Merlini L, Tonia FM, Chevallay M, Gobbi G. Laminin alpha 2 chain negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Brain Dev 1996;18 (4):316-322.
31. Osari S, Kobayashi O, Yamashita Y, et al. Basement membrane abnormality in laminin α2 chain-negative congenital muscular dystrophy. Acta Neuropathol 1996;91:332-336.
32. Minetti C, Bado M, Morreale G, Pedemonte M, Cordone G. Disruption of muscle basal lamina in congenital muscular dystrophy with laminin α2 chain deficiency. Neurology 1996;46:1354-1358.
33. Arahata K, Hayashi YK, Koga R, et al. Basement membrane abnormality in laminin α2 chain-negative congenital muscular dystrophy: defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Jpn Acad Ser B 1993;69:259-264.
34. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Demyelinating peripheral neuropathy in laminin α2 chain-deficient congenital muscular dystrophy. J Child Neurol 1995;10 (6):472-475.
35. Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromusc Disord 1997;7:7-12.
36. Malandrini A, Villanova M, Sabatelli P, et al. Localization of the laminin alpha 2 chain in normal human skeletal and peripheral nerve: an ultrastructural immunolabeling study. Acta Neuropathol 1997;93: 166-172.